Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.
暂无分享,去创建一个
K K Kidd | B Wendel | G. Church | K. Kidd | W. Berrettini | M. Hoehe | K. Rohde | W H Berrettini | G M Church | B. Wendel | M. Hoehe | K. Köpke | C. Flachmeier | M R Hoehe | K Köpke | K Rohde | C Flachmeier
[1] Francis S. Collins,et al. Variations on a Theme: Cataloging Human DNA Sequence Variation , 1997, Science.
[2] W. Berrettini,et al. Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans , 1996, Biological Psychiatry.
[3] S. Tavaré,et al. Polymorphisms in the human DNA repair gene XPF. , 1999, Mutation research.
[4] C R Scriver,et al. Mutation nomenclature: Nicknames, systematic names, and unique identifiers , 1996, Human mutation.
[5] J. Volpicelli,et al. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence , 1997, Psychopharmacology.
[6] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[7] R. Evie. Opioids: first lessons from knockout mice , 1999 .
[8] G. De Soete,et al. Clustering and Classification , 2019, Data-Driven Science and Engineering.
[9] S. Antonarakis. Recommendations for a nomenclature system for human gene mutations , 1998 .
[10] H. Schulman,et al. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] G. Church,et al. Multiplex DNA sequencing. , 1988, Science.
[12] P. Richterich,et al. DNA sequencing with direct transfer electrophoresis and nonradioactive detection. , 1993, Methods in enzymology.
[13] M. Rieder,et al. Sequence variation in the human angiotensin converting enzyme , 1999, Nature Genetics.
[14] Robert F. Dannals,et al. Increased mu opioid receptor binding detected by PET in cocaine–dependent men is associated with cocaine craving , 1996, Nature Medicine.
[15] K. Kidd,et al. HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. , 1995, The Journal of heredity.
[16] Cyrus R. Mehta,et al. A hybrid algorithm for fisher's exact test in unordered rxc contingency tables , 1986 .
[17] J. Witte,et al. Genetic dissection of complex traits , 1996, Nature Genetics.
[18] A. Templeton. Cladistic approaches to identifying determinants of variability in multifactorial phenotypes and the evolutionary significance of variation in the human genome. , 2007, Ciba Foundation symposium.
[19] S. Delbrück,et al. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. , 1997, Cytogenetics and cell genetics.
[20] C. Sing,et al. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. , 1992, Genetics.
[21] Phipps Arabie,et al. AN OVERVIEW OF COMBINATORIAL DATA ANALYSIS , 1996 .
[22] A. Chakravarti. It's raining SNPs, hallelujah? , 1998, Nature Genetics.
[23] I. Sora,et al. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] Nitin R. Patel,et al. A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .
[25] T. Wienker,et al. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. , 1998, Kidney international.
[26] Brigitte L. Kieffer,et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.
[27] N. Saitou,et al. The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.
[28] A. Hajeer. The Genetic Variation and Human Disease: Principles and Evolutionary Approaches , 1996 .
[29] K. Kidd,et al. Population frequencies of the A1 allele at the dopamine D2 receptor locus , 1993, Biological Psychiatry.
[30] M. Hasegawa,et al. Relative efficiencies of the maximum likelihood, maximum parsimony, and neighbor-joining methods for estimating protein phylogeny. , 1993, Molecular phylogenetics and evolution.
[31] S. Tishkoff,et al. Global Patterns of Linkage Disequilibrium at the CD4 Locus and Modern Human Origins , 1996, Science.
[32] J A Tischfield,et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] Peter Beighton,et al. de la Chapelle, A. , 1997 .
[34] G. Carey. Genetic association study in psychiatry: analytical evaluation and a recommendation. , 1994, American journal of medical genetics.
[35] Francis S. Collins,et al. Positional cloning moves from perditional to traditional , 1995, Nature Genetics.
[36] W. Vogel,et al. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains , 1994, Nature Genetics.
[37] E. Boerwinkle,et al. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. , 1998, American journal of human genetics.
[38] Update on nomenclature for human gene mutations. Ad Hoc Committee on Mutation Nomenclature. , 1996, Human mutation.
[39] G. Uhl,et al. Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.
[40] E. Boerwinkle,et al. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. , 1987, Genetics.
[41] E. Boerwinkle,et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene , 1998, Nature Genetics.
[42] James R. Eshleman,et al. Conversion of diploidy to haploidy , 2000, Nature.
[43] E. Ochoa Mangado. [Naltrexone in the treatment of alcohol dependence]. , 1998, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.
[44] E. Brody,et al. An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. , 1995, Nucleic acids research.
[45] E. Lander,et al. Genetic dissection of complex traits science , 1994 .
[46] Wilkie,et al. Genetics of disease. , 1996, Current opinion in genetics & development.
[47] Nitin R. Patel,et al. ALGORITHM 643: FEXACT: a FORTRAN subroutine for Fisher's exact test on unordered r×c contingency tables , 1986, TOMS.
[48] M. Kreek. Opiates, opioids and addiction. , 1996, Molecular psychiatry.
[49] K. Kidd,et al. Associations of disease with genetic markers: déjà vu all over again. , 1993, American journal of medical genetics.
[50] M. Smolka,et al. Human μ‐Opioid Receptor Variation and Alcohol Dependence , 1998 .
[51] W. Berrettini,et al. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse , 1997, Addiction biology.
[52] J. Nurnberger,et al. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.
[53] A. Valdés,et al. Detecting disease-predisposing variants: the haplotype method. , 1997, American journal of human genetics.
[54] M. Hoehe,et al. The human µ opioid receptor gene: 5´ regulatory and intronic sequences , 1998, Journal of Molecular Medicine.
[55] J. Long,et al. μ opioid receptor gene variants: lack of association with alcohol dependence , 1997, Molecular Psychiatry.
[56] A. Herz. Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.
[57] K. Weiss. Is there a paradigm shift in genetics? Lessons from the study of human diseases. , 1996, Molecular phylogenetics and evolution.
[58] N. Schork,et al. Issues and strategies in the genetic analysis of alcoholism and related addictive behaviors. , 1998, Alcohol.
[59] Alan Agresti,et al. Exact Inference for Contingency Tables with Ordered Categories , 1990 .
[60] E. Lander. The New Genomics: Global Views of Biology , 1996, Science.
[61] A. Templeton,et al. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus. , 1995, Genetics.
[62] T. Duka,et al. Dose-dependent influence of Fentanyl on prolactin, growth hormone, and mood , 1984, Neuropeptides.
[63] L. Excoffier,et al. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.
[64] G. Golden,et al. The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice. , 1997, Life sciences.
[65] M. Nei. Molecular Evolutionary Genetics , 1987 .
[66] J. Terwilliger. Genetic Variation and Human Disease: Principles and Evolutionary Approaches , 1997 .
[67] K. Weiss,et al. Linkage disequilibrium mapping of complex disease: fantasy or reality? , 1998, Current opinion in biotechnology.
[68] Y. Koda,et al. Allelic diversity of the human plasma α(1,3)fucosyltransferase gene (FUT6) , 1999 .
[69] C. Mazure,et al. Blindness and reliability in lifetime psychiatric diagnosis. , 1979, Archives of general psychiatry.